Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

276.22 

-3.30 -1.2%

as of Aug 20 '19

52 Week Range:

208.34 305.43


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. It serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis equipment; laboratory plastics and chemicals; and pharma services. Thermo Fisher Scientific Inc. has a strategic collaboration with NX Prenatal Inc. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Oct '16 Dec '17 Dec '18
Equity (BVPS) 35.52
37.70
39.25
40.92
43.26
45.41
51.22
52.17
55.05
61.55
66.87
growth rate 6.1% 4.1% 4.3% 5.7% 5.0% 12.8% 1.9% 5.5% 11.8% 8.6%
Earnings BIT 1,150.00
927.10
1,160.00
1,130.00
1,270.00
1,320.00
2,284.50
2,502.00
2,805.00
3,221.00
3,889.00
growth rate -19.4% 25.1% -2.6% 12.4% 3.9% 73.1% 9.5% 12.1% 14.8% 20.7%
Avg.PE 15.02
23.75
21.98
16.98
18.59
31.85
27.62
28.53
31.46
37.75
34.87
growth rate 58.1% -7.5% -22.8% 9.5% 71.3% -13.3% 3.3% 10.3% 20.0% -7.6%
ROA 4.70
3.98
4.82
5.52
4.34
4.29
5.07
4.72
4.66
4.34
5.20
growth rate -15.3% 21.1% 14.5% -21.4% -1.2% 18.2% -6.9% -1.3% -6.9% 19.8%
ROE 6.76
5.60
6.73
8.75
7.72
7.88
10.13
9.43
9.43
9.48
11.09
growth rate -17.2% 20.2% 30.0% -11.8% 2.1% 28.6% -6.9% 0.0% 0.5% 17.0%
ROIC 5.91
5.46
6.26
7.40
6.24
6.01
7.32
6.82
6.78
6.37
7.35
growth rate -7.6% 14.7% 18.2% -15.7% -3.7% 21.8% -6.8% -0.6% -6.1% 15.4%
Cur. Ratio 2.82
2.76
2.42
1.55
2.31
3.16
1.22
1.38
1.44
1.34
1.73
growth rate -2.1% -12.3% -36.0% 49.0% 36.8% -61.4% 13.1% 4.4% -6.9% 29.1%
Quick Ratio 1.80
1.82
1.43
0.91
1.27
2.49
0.72
0.72
0.87
0.80
1.01
growth rate 1.1% -21.4% -36.4% 39.6% 96.1% -71.1% 0.0% 20.8% -8.1% 26.3%
Leverage 1.41
1.40
1.39
1.78
1.77
1.89
2.09
1.92
2.13
2.23
2.04
growth rate -0.7% -0.7% 28.1% -0.6% 6.8% 10.6% -8.1% 10.9% 4.7% -8.5%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Oct '16 Dec '17 Dec '18
Acct.Receivable 1,478.10
1,409.60
1,473.80
1,921.50
1,986.90
2,134.80
2,473.60
2,763.00
3,427.00
3,879.00
4,595.00
growth rate -4.6% 4.6% 30.4% 3.4% 7.4% 15.9% 11.7% 24.0% 13.2% 18.5%
Acct.Payable 1,647.80
1,803.70
1,939.40
820.70
822.20
926.00
1,428.00
1,615.00
growth rate 9.5% 7.5% -57.7% 0.2% 12.6% 54.2% 13.1%
Cur.Assets 4,345.90
4,530.90
4,135.00
4,821.90
4,834.80
9,880.70
6,539.80
5,741.20
7,021.00
9,421.00
10,625.00
growth rate 4.3% -8.7% 16.6% 0.3% 104.4% -33.8% -12.2% 22.3% 34.2% 12.8%
Total Assets 21,090.00
21,625.00
21,349.40
26,833.70
27,444.60
31,863.40
42,852.10
40,834.30
45,908.00
56,669.00
56,232.00
growth rate 2.5% -1.3% 25.7% 2.3% 16.1% 34.5% -4.7% 12.4% 23.4% -0.8%
Cash 1,280.50
1,564.10
917.10
1,016.30
805.60
5,826.00
1,343.50
452.10
786.00
1,335.00
2,103.00
growth rate 22.2% -41.4% 10.8% -20.7% 623.2% -76.9% -66.4% 73.9% 69.9% 57.5%
Inventory 1,171.40
1,131.40
1,172.90
1,330.10
1,443.30
1,494.50
1,859.50
1,991.70
2,213.00
2,971.00
3,005.00
growth rate -3.4% 3.7% 13.4% 8.5% 3.6% 24.4% 7.1% 11.1% 34.3% 1.1%
Cur.Liabilities 1,540.20
1,639.30
1,709.80
3,113.10
2,093.30
3,126.00
5,349.80
4,146.30
4,866.00
7,048.00
6,147.00
growth rate 6.4% 4.3% 82.1% -32.8% 49.3% 71.1% -22.5% 17.4% 44.8% -12.8%
Liabilities 6,163.50
6,194.10
5,988.40
11,795.60
11,979.90
15,007.30
22,304.00
19,484.10
24,368.00
31,256.00
28,646.00
growth rate 0.5% -3.3% 97.0% 1.6% 25.3% 48.6% -12.6% 25.1% 28.3% -8.4%
LT Debt 2,027.40
2,065.90
2,031.30
5,755.20
7,031.20
9,499.60
12,351.60
11,436.60
15,482.00
18,997.00
17,839.00
growth rate 1.9% -1.7% 183.3% 22.2% 35.1% 30.0% -7.4% 35.4% 22.7% -6.1%
Equity 14,926.50
15,430.90
15,361.00
15,038.10
15,464.70
16,856.10
20,548.10
21,350.20
21,540.00
25,413.00
27,586.00
growth rate 3.4% -0.5% -2.1% 2.8% 9.0% 21.9% 3.9% 0.9% 18.0% 8.6%
Common Shares 434.00
423.00
409.00
385.00
367.00
366.00
402.00
411.90
415.00
428.00
432.00
growth rate -2.5% -3.3% -5.9% -4.7% -0.3% 9.8% 2.5% 0.8% 3.1% 0.9%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Oct '16 Dec '17 Dec '18
Capital Expenditures 249.00
194.10
247.60
260.90
315.10
282.40
427.60
423.00
444.00
508.00
758.00
growth rate -22.1% 27.6% 5.4% 20.8% -10.4% 51.4% -1.1% 5.0% 14.4% 49.2%
Cash Dividends 0.00
0.00
0.00
0.00
142.20
216.20
234.80
241.00
238.00
237.00
266.00
growth rate 52.0% 8.6% 2.6% -1.2% -0.4% 12.2%
Cash From OA 1,420.20
1,659.20
1,497.80
1,691.00
2,039.50
2,010.70
2,619.60
2,942.00
3,258.00
4,005.00
4,543.00
growth rate 16.8% -9.7% 12.9% 20.6% -1.4% 30.3% 12.3% 10.7% 22.9% 13.4%
FCF per Share 2.66
3.43
3.01
3.10
4.70
4.54
5.15
5.20
6.87
7.11
9.66
growth rate 29.0% -12.2% 3.0% 51.6% -3.4% 13.4% 1.0% 32.1% 3.5% 35.9%
Sale Purchase of Stock -1,179.40
-895.90
140.60
3,097.40
72.00
87.00
1,818.00
growth rate 0.0% 100.0% 2,103.0% -97.7% 20.8% 1,989.7%
FCF 1,155.00
1,452.00
1,232.00
1,425.00
1,724.00
1,728.00
2,192.00
2,394.00
2,712.00
3,497.00
3,785.00
growth rate 25.7% -15.2% 15.7% 21.0% 0.2% 26.9% 9.2% 13.3% 29.0% 8.2%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Oct '16 Dec '17 Dec '18
Sales 10,498.00
10,109.70
10,570.20
11,558.80
12,509.90
13,090.30
16,889.60
16,965.00
18,274.00
20,918.00
24,358.00
growth rate -3.7% 4.6% 9.4% 8.2% 4.6% 29.0% 0.5% 7.7% 14.5% 16.5%
Op.Income 1,229.40
1,048.90
1,206.00
1,023.40
1,258.40
1,279.10
2,284.50
2,502.00
2,805.00
3,221.00
3,889.00
growth rate -14.7% 15.0% -15.1% 23.0% 1.6% 78.6% 9.5% 12.1% 14.8% 20.7%
IBT 1,128.00
927.10
1,105.70
1,132.80
1,269.40
1,319.50
2,087.20
1,936.00
2,024.00
2,429.00
3,262.00
growth rate -17.8% 19.3% 2.5% 12.1% 4.0% 58.2% -7.2% 4.6% 20.0% 34.3%
Net Income 980.90
850.30
1,035.60
1,023.40
1,258.40
1,279.10
1,894.40
1,975.00
2,022.00
2,225.00
2,938.00
growth rate -13.3% 21.8% -1.2% 23.0% 1.6% 48.1% 4.3% 2.4% 10.0% 32.0%
EPS 2.25
2.01
2.53
3.46
3.21
3.48
4.71
4.92
5.09
5.59
7.24
growth rate -10.7% 25.9% 36.8% -7.2% 8.4% 35.3% 4.5% 3.5% 9.8% 29.5%
Gross Profit 4,206.20
4,024.70
4,297.20
4,794.00
5,295.50
5,529.10
7,798.00
7,765.00
8,449.00
9,536.00
10,869.00
growth rate -4.3% 6.8% 11.6% 10.5% 4.4% 41.0% -0.4% 8.8% 12.9% 14.0%
R&D 249.10
246.10
284.80
340.20
376.40
395.50
691.10
692.00
754.00
887.00
967.00
growth rate -1.2% 15.7% 19.5% 10.6% 5.1% 74.7% 0.1% 9.0% 17.6% 9.0%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 962.00
880.00
1,208.00
948.00
1,050.00
growth rate -8.5% 37.3% -21.5% 10.8%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 4,912.00
4,719.00
4,595.00
4,700.00
4,775.00
growth rate -3.9% -2.6% 2.3% 1.6%
Acct.Payable 1,359.00
1,344.00
1,615.00
1,462.00
1,391.00
growth rate -1.1% 20.2% -9.5% -4.9%
Cur.Assets 9,474.00
9,566.00
10,625.00
9,939.00
11,223.00
growth rate 1.0% 11.1% -6.5% 12.9%
Total Assets 55,403.00
55,078.00
56,232.00
55,596.00
57,970.00
growth rate -0.6% 2.1% -1.1% 4.3%
Cash 937.00
1,098.00
2,103.00
1,106.00
2,288.00
growth rate 17.2% 91.5% -47.4% 106.9%
Inventory 2,866.00
2,982.00
3,005.00
3,124.00
3,209.00
growth rate 4.1% 0.8% 4.0% 2.7%
Cur.Liabilities 5,980.00
5,196.00
6,147.00
5,898.00
7,509.00
growth rate -13.1% 18.3% -4.1% 27.3%
Liabilities 28,958.00
28,188.00
28,646.00
27,903.00
29,241.00
growth rate -2.7% 1.6% -2.6% 4.8%
LT Debt 17,881.00
17,940.00
17,839.00
16,912.00
16,709.00
growth rate 0.3% -0.6% -5.2% -1.2%
Equity 26,445.00
26,890.00
27,586.00
27,693.00
28,729.00
growth rate 1.7% 2.6% 0.4% 3.7%
Common Shares 430.00
431.00
432.00
433.00
433.00
growth rate 0.2% 0.2% 0.2% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 183.00
173.00
284.00
201.00
220.00
growth rate -5.5% 64.2% -29.2% 9.5%
Cash Dividends 69.00
69.00
68.00
68.00
76.00
growth rate 0.0% -1.5% 0.0% 11.8%
Cash From OA 1,444.00
1,220.00
1,801.00
649.00
1,294.00
growth rate -15.5% 47.6% -64.0% 99.4%
Sale Purchase of Stock 39.00
growth rate
FCF 1,261.00
1,047.00
1,517.00
448.00
1,074.00
growth rate -17.0% 44.9% -70.5% 139.7%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 6,078.00
5,920.00
6,507.00
6,125.00
6,316.00
growth rate -2.6% 9.9% -5.9% 3.1%
Op.Income 962.00
880.00
1,208.00
948.00
1,050.00
growth rate -8.5% 37.3% -21.5% 10.8%
IBT 806.00
810.00
1,012.00
817.00
1,393.00
growth rate 0.5% 24.9% -19.3% 70.5%
Net Income 752.00
709.00
898.00
815.00
1,119.00
growth rate -5.7% 26.7% -9.2% 37.3%
EPS
growth rate
Gross Profit 2,743.00
2,614.00
2,929.00
2,713.00
2,828.00
growth rate -4.7% 12.1% -7.4% 4.2%
R&D 242.00
240.00
251.00
248.00
246.00
growth rate -0.8% 4.6% -1.2% -0.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (86.03)

YOY Growth Grade:

C (58.67)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 35.48 35.28 20.55
EPS / Growth 14.0% 7.83 11.8%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 8.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 8.8% 11.5% 11.5%
Future PE 17.68 26.36 26.36
Future EPS 18.27 23.32 23.32
Value Price
MOS %
79.83
-71.1%
151.95
-45.0%
151.95
-45.0%
MOS Price 39.91 75.97 75.97
IRT 15.96 14.07 14.07

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.